NICE vs ADA - which guideline should we follow? (Secondary care and primary care joint session)

This session aims to look at the available evidence based guidelines for management of Type 2 Diabetes. It will highlight the differences between the current NICE guidance and the new ADA/EASD guidance that has been released. We will discuss the reasons for these differences and implications for formulary choices and clinical decision making.

This will map to 1.6, 1.7, 4.1, 4.3 – there will be a variety of levels of discussion in this presentation. We will aim to cover AL1 to Mastery.

I have worked as a General practitioner since 1998. Special Interest Adult Diabetes and Obesity. Local primary care lead for Diabetes (PCT and now CCG) since 2006.
I also work part-time as a GPwSI Diabetes at County Durham and Darlington Foundation and part-time NIHR CRN Primary Care Diabetes Lead for the North-East. 
Proud to be part of the team to have delivered one of the largest integrated diabetes models in England, recently rewarded at the 2017 QiC national awards and shortlisted for the 2018 HSJ Improving Value Awards. Still a work in progress.
Committee Member of Primary Care Diabetes Society.

Hannah Beba is a Senior Pharmacist for Diabetes and Endocrinology at County Durham and Darlington NHS Foundation Trust. Hannah sits on the United Kingdom Clinical Pharmacy Associations Endocrine Committee, the Diabetes Clinical Advisory Group Committee for County Durham and Darlington and Chairs the Medical Pharmacists Group Committee for her NHS trust. Hannah is also a Diabetes UK Clinical Champion. This allows her to take an active role designing and shaping regional and national agendas, aiding guideline development and delivering quality education both locally and nationally.

Hannah retains a predominantly clinical role and is an independent prescriber; she is working towards becoming a consultant pharmacist. Hannah has been independently practicing in clinics for many years, laterally in diabetes/endocrine clinics across both primary and secondary care.

Hannah is interested in delivery of better integrated care for diabetic patients and recent projects have involved delivery of a specialist led diabetic clinic in primary care and an engagement project with community pharmacy.